PMC:7712180 / 81401-81770 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2845","span":{"begin":296,"end":298},"obj":"Gene"},{"id":"2846","span":{"begin":252,"end":254},"obj":"Gene"},{"id":"2854","span":{"begin":25,"end":33},"obj":"Species"},{"id":"2855","span":{"begin":135,"end":144},"obj":"Species"},{"id":"2856","span":{"begin":145,"end":150},"obj":"Species"},{"id":"2857","span":{"begin":175,"end":180},"obj":"Species"},{"id":"2858","span":{"begin":325,"end":336},"obj":"Species"},{"id":"2873","span":{"begin":98,"end":107},"obj":"Disease"}],"attributes":[{"id":"A2845","pred":"tao:has_database_id","subj":"2845","obj":"Gene:170589"},{"id":"A2846","pred":"tao:has_database_id","subj":"2846","obj":"Gene:170589"},{"id":"A2854","pred":"tao:has_database_id","subj":"2854","obj":"Tax:1335626"},{"id":"A2855","pred":"tao:has_database_id","subj":"2855","obj":"Tax:9838"},{"id":"A2856","pred":"tao:has_database_id","subj":"2856","obj":"Tax:9838"},{"id":"A2857","pred":"tao:has_database_id","subj":"2857","obj":"Tax:9606"},{"id":"A2858","pred":"tao:has_database_id","subj":"2858","obj":"Tax:59474"},{"id":"A2873","pred":"tao:has_database_id","subj":"2873","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Accordingly, multivalent MERS-CoV S1A-containing nanoparticles were shown to specifically bind to infection sites in individual hosts: dromedary camel nasal epithelial cells, human type II pneumocytes in the alveolar wall that contains an abundance of α2,3-sialyl type 2 LN and a small amount of α2,3-sialyl-LewisX [19], and pipistrelle bat intestinal epithelial cells."}

{"project":"LitCovid-sentences","denotations":[{"id":"T430","span":{"begin":0,"end":369},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Accordingly, multivalent MERS-CoV S1A-containing nanoparticles were shown to specifically bind to infection sites in individual hosts: dromedary camel nasal epithelial cells, human type II pneumocytes in the alveolar wall that contains an abundance of α2,3-sialyl type 2 LN and a small amount of α2,3-sialyl-LewisX [19], and pipistrelle bat intestinal epithelial cells."}